# Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens

> **NCT01275274** · PHASE2 · WITHDRAWN · sponsor: **University of North Carolina, Chapel Hill**

## Conditions studied

- Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

## Interventions

- **DRUG:** Retinoic acid
- **DRUG:** Standard of care

## Key facts

- **NCT ID:** NCT01275274
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-01
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** no subject enrolled in nearly 2 years
- **Last updated:** 2017-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01275274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01275274, "Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01275274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*